SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19609859
Source:
http://linkedlifedata.com/resource/pubmed/id/19609859
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0220901
,
umls-concept:C0237881
,
umls-concept:C0750502
,
umls-concept:C1332034
,
umls-concept:C1335302
pubmed:issue
9
pubmed:dateCreated
2009-7-17
pubmed:abstractText
The human Anterior Gradient-2 (AGR2) is strongly upregulated in various human cancers, including pancreatic ductal adenocarcinomas (PDAC), but its prognostic value in PDAC has not yet been studied.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8609357
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/AGR2 protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1699-5848
pubmed:author
pubmed-author:BahraMarcusM
,
pubmed-author:FritzscheFlorian RFR
,
pubmed-author:GerhardtJosefineJ
,
pubmed-author:GrützmannRobertR
,
pubmed-author:KristiansenGlenG
,
pubmed-author:PilarskyChristianC
,
pubmed-author:RienerMarc-OliverMO
,
pubmed-author:WeichertWilkoW
pubmed:issnType
Electronic
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1121-8
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19609859-Adenocarcinoma
,
pubmed-meshheading:19609859-Aged
,
pubmed-meshheading:19609859-Antibodies, Monoclonal
,
pubmed-meshheading:19609859-Carcinoma, Pancreatic Ductal
,
pubmed-meshheading:19609859-Cell Line
,
pubmed-meshheading:19609859-Cell Line, Tumor
,
pubmed-meshheading:19609859-Female
,
pubmed-meshheading:19609859-Follow-Up Studies
,
pubmed-meshheading:19609859-Gene Expression Regulation, Neoplastic
,
pubmed-meshheading:19609859-Humans
,
pubmed-meshheading:19609859-Immunohistochemistry
,
pubmed-meshheading:19609859-Kaplan-Meier Estimate
,
pubmed-meshheading:19609859-Male
,
pubmed-meshheading:19609859-Microdissection
,
pubmed-meshheading:19609859-Pancreatic Neoplasms
,
pubmed-meshheading:19609859-Prognosis
,
pubmed-meshheading:19609859-Proteins
,
pubmed-meshheading:19609859-RNA, Messenger
,
pubmed-meshheading:19609859-Sex Factors
,
pubmed-meshheading:19609859-Survival Analysis
,
pubmed-meshheading:19609859-Time Factors
,
pubmed-meshheading:19609859-Tissue Array Analysis
pubmed:year
2009
pubmed:articleTitle
Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma.
pubmed:affiliation
Institute of Surgical Pathology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland.
pubmed:publicationType
Journal Article